Entera Bio Ltd. ENTX

Full chart Compare
Set alert

Price alert · ENTX

All alert types
3.05 USD -0.04 (-1.29%)

At closeNov 3, 2026, 4:00 PM EST

3.05 0.00 0.00%

After hours · Nov 3, 4:00 PM ET

2.99 Day range 3.12
0.91 52-week range 4.20
YTD
+57.22%
1 year
+7.39%

Financial health

Altman Z-Score

14.89 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E -7.8×
FY 2016: -44.9×FY 2017: -4.8×FY 2018: -3.4×FY 2019: -2.4×FY 2020: -2.0×FY 2021: -6.0×FY 2022: -1.6×FY 2023: -1.9×FY 2024: -8.5×FY 2025: -7.8×
FY 2016 5y median -6.0× FY 2025
P/S 2134×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 69.4×FY 2019: 110×FY 2020: 54.5×FY 2021: 129×FY 2022: 157×FY 2023: 0.0×FY 2024: 441×FY 2025: 2134×
FY 2016 5y median 157× FY 2025
P/B 6.8×
FY 2016: -2.1×FY 2017: -1.7×FY 2018: 3.4×FY 2019: 2.2×FY 2020: 2.6×FY 2021: 3.3×FY 2022: 1.8×FY 2023: 1.7×FY 2024: 9.9×FY 2025: 6.8×
FY 2016 5y median 3.3× FY 2025
P/FCF -12.0×
FY 2016: -16.9×FY 2017: -11.8×FY 2018: -3.5×FY 2019: -2.9×FY 2020: -1.9×FY 2021: -8.1×FY 2022: -1.7×FY 2023: -2.4×FY 2024: -11.7×FY 2025: -12.0×
FY 2016 5y median -8.1× FY 2025
EV/EBITDA -7.3×
FY 2016: -12.1×FY 2017: -4.2×FY 2018: -2.5×FY 2019: -1.1×FY 2020: -1.1×FY 2021: -4.0×FY 2022: -0.7×FY 2023: -0.8×FY 2024: -7.5×FY 2025: -7.3×
FY 2016 5y median -4.0× FY 2025
EV/Sales 1976×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 54.4×FY 2019: 46.9×FY 2020: 32.1×FY 2021: 86.0×FY 2022: 65.8×FY 2023: 0.0×FY 2024: 395×FY 2025: 1976×
FY 2016 5y median 86.0× FY 2025
FCF Yield -8.3%
FY 2016: -5.9%FY 2017: -8.5%FY 2018: -28.4%FY 2019: -34.5%FY 2020: -53.3%FY 2021: -12.3%FY 2022: -59.7%FY 2023: -42.1%FY 2024: -8.5%FY 2025: -8.3%
FY 2016 5y median -12.3% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 100.0%FY 2019: -89.8%FY 2020: 17.8%FY 2021: 34.7%FY 2022: -23.1%FY 2023: 0.0%FY 2024: 5.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin -27450.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -2172.2%FY 2019: -4853.4%FY 2020: -3059.7%FY 2021: -2139.6%FY 2022: -9752.2%FY 2023: 0.0%FY 2024: -5295.6%FY 2025: -27450.0%
FY 2016 5y median -5295.6% FY 2025
Net Margin -27235.7%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -2060.8%FY 2019: -4574.2%FY 2020: -3072.9%FY 2021: -2134.3%FY 2022: -9754.5%FY 2023: 0.0%FY 2024: -5271.3%FY 2025: -27235.7%
FY 2016 5y median -5271.3% FY 2025
ROE -87.3%
FY 2016: 4.7%FY 2017: 35.5%FY 2018: -101.9%FY 2019: -90.6%FY 2020: -149.3%FY 2021: -54.0%FY 2022: -111.2%FY 2023: -85.6%FY 2024: -118.1%FY 2025: -87.3%
FY 2016 5y median -87.3% FY 2025
ROIC -218.8%
FY 2016: -95.3%FY 2017: 99.4%FY 2018: -94.0%FY 2019: -93.2%FY 2020: -138.4%FY 2021: -52.8%FY 2022: -110.0%FY 2023: -82.7%FY 2024: -114.3%FY 2025: -218.8%
FY 2016 5y median -110.0% FY 2025
ROA -71.5%
FY 2016: -19.1%FY 2017: -84.3%FY 2018: -77.2%FY 2019: -64.6%FY 2020: -115.4%FY 2021: -46.9%FY 2022: -99.6%FY 2023: -75.6%FY 2024: -101.6%FY 2025: -71.5%
FY 2016 5y median -75.6% FY 2025

Growth (YoY)

Revenue -76.8%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -52.8%FY 2020: 54.7%FY 2021: 56.4%FY 2022: -76.5%FY 2023: -100.0%FY 2024: 0.0%FY 2025: -76.8%
FY 2016 FY 2025
Operating Income -20.3%
FY 2016: -45.0%FY 2017: 311.3%FY 2018: -195.8%FY 2019: -5.5%FY 2020: 2.5%FY 2021: -9.4%FY 2022: -7.0%FY 2023: 31.6%FY 2024: -7.2%FY 2025: -20.3%
FY 2016 FY 2025
EPS (diluted) 0.0%
FY 2016: 72.2%FY 2017: -840.0%FY 2018: -37.2%FY 2019: 30.2%FY 2020: 40.0%FY 2021: 13.0%FY 2022: 4.3%FY 2023: 31.1%FY 2024: 19.4%FY 2025: 0.0%
FY 2016 FY 2025
Free Cash Flow -9.6%
FY 2016: 10.3%FY 2017: -43.8%FY 2018: -115.5%FY 2019: 9.2%FY 2020: -18.4%FY 2021: 14.4%FY 2022: -38.2%FY 2023: 41.6%FY 2024: 6.9%FY 2025: -9.6%
FY 2016 FY 2025

Financial Health

Current Ratio 3.2×
FY 2016: 0.5×FY 2017: 6.1×FY 2018: 7.0×FY 2019: 3.4×FY 2020: 4.9×FY 2021: 8.0×FY 2022: 9.6×FY 2023: 10.3×FY 2024: 7.6×FY 2025: 3.2×
FY 2016 5y median 8.0× FY 2025
Quick Ratio 3.2×
FY 2016: 0.5×FY 2017: 6.1×FY 2018: 6.9×FY 2019: 3.4×FY 2020: 4.9×FY 2021: 8.0×FY 2022: 9.6×FY 2023: 10.3×FY 2024: 7.6×FY 2025: 3.2×
FY 2016 5y median 8.0× FY 2025
Debt / Equity 0.0×
FY 2016: -0.6×FY 2017: -0.1×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.6×
FY 2016: -2.0×FY 2017: 0.7×FY 2018: 0.7×FY 2019: 1.4×FY 2020: 0.7×FY 2021: 2.0×FY 2022: 0.9×FY 2023: 1.2×FY 2024: 0.9×FY 2025: 0.6×
FY 2016 5y median 0.9× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -136×FY 2020: -399×FY 2021: -421×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31